ArticleJournal of pharmaceutical sciences2021

Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens.

Nishant Sawant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.